✉news HealthNutrition first seen 7 d ago, last 7 d ago, peak #6
Pharma standards and GLP-1 trends reshape nutraceuticals after CPHI Milan
Original: CPHI Milan 2026 review: Pharma standards and GLP-1 trends reshape nutraceuticals
A review of CPHI Milan 2026 highlights how pharmaceutical manufacturing standards and the surge around GLP-1 drugs are reshaping the nutraceuticals industry. Exhibitors and analysts reportedly discussed tighter quality expectations and shifting consumer interest as companies in the supplements sector adapt their strategies in response to the weight-loss drug boom.
Why now: The nutraceuticals industry is assessing how GLP-1 drugs and stricter pharma-grade quality expectations will affect its market.
CPHI Milan 2026GLP-1Nutraceuticals industry
Evidence
- CPHI Milan 2026 review: Pharma standards and GLP-1 trends reshape nutraceuticals · Nutrition Insight
API: https://socialmediatrends-api.osmike.com/v1/trends/2221099